 rel efficaci antithrombin antiplatelet agent coronari thrombolysi earli reocclus background optim coronari thrombolysi prompt persist activ platelet thrombin activ clinic thrombolysi role thrombolysi earli coronari reocclus difficult method result consciou dog coronari thrombosi electr current impact rapid thrombolysi incid reocclus type adjunct treatment intraven tissue-typ plasminogen activ t-pa inhibit platelet function peptid mimet antagonist platelet glycoprotein iib/iiia receptor lysin acetylsalicyl acid asa inhibit thrombin activ recombin hirudin heparin asa receptor antagonist time t-pa mean SD minut asa minut receptor antagonist minut salin control reocclus complet infus t-pa dog salin reocclus dog minut end infus t-pa antiplatelet agent continu inhibit platelet function dog asa receptor antagonist contrast inhibit thrombin activ recombin hirudin dose partial thromboplastin time acceler lysi minut prevent reocclus dog heparin dose similar prolong partial thromboplastin time lysi prevent reocclus dog conclus inhibit thrombin recombin hirudin facilit thrombolysi patenc coronari arteri t-pa benefit direct anticoagul effect diminish activ platelet secondari decreas thrombin activ